+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of acute leukemia in childhood with liposomal daunorubicin



Treatment of acute leukemia in childhood with liposomal daunorubicin



Annals of Hematology 78(SUPPL 2): S41




(PDF emailed within 1 workday: $29.90)

Accession: 035980775

Download citation: RISBibTeXText


Related references

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome. Cancer 97(5): 1234-1241, 2003

Liposomal daunorubicin for childhood acute lymphoblastic leukemia A phase I-II study. Blood 92(10 SUPPL 1 PART 1-2): 234A, Nov 15, 1998

Liposomal daunorubicin is cytotoxic to childhood acute lymphoblastic leukemia cells. Blood 90(10 SUPPL 1 PART 2): 201B, Nov 15, 1997

Liposomal Daunorubicin in the treatment of acute leukemia. Blood 94(10 SUPPL 1 PART 1): 508a, Nov 15, 1999

Liposomal daunorubicin results in higher plasma concentrations but similar intracellular concentrations in leukemic cells compared to non-encapsulated daunorubicin during induction treatment in acute myeloid leukemia. Blood 102(11): 255b, November 16, 2003

Liposomal daunorubicin in the treatment of acute lymphocytic leukemia. Blood 96(11 Part 1): 720a, November 16, 2000

A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia. Haematologica 91(11): 1573-1574, 2006

Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia. Terapevticheskii Arkhiv 71(7): 24-27, 1999

Liposomal daunorubicin for treatment of relapsed meningeal acute myeloid leukemia. Leukemia (Basingstoke) 16(9): 1880-1881, September, 2002

Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia. Annals of Hematology 81(8): 462-466, 2002

Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia. Therapeutic Drug Monitoring 29(5): 626-631, 2007

Treatment of newly diagnosed acute myelogenous leukemia adults younger than age 55 with liposomal daunorubicin and ARA-C. Blood 96(11 Part 2): 210b, November 16, 2000

Treatment of newly diagnosed acute myelogenous leukemia adults younger than age 56 with liposomal daunorubicin and ARA-C. Blood 98(11 Part 2): 211b-212b, November 16, 2001

Successful treatment of hepatosplenic candidiasis in an elderly patient with acute myeloid leukemia using liposomal daunorubicin and fluconazole. Haematologica 86(8): E18-E18, 2001

Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia. Terapevticheskii Arkhiv 74(7): 11-18, 2002